Prestigious Collen-Francqui Start-Up Grant for VUB scientist Kiavash Movahedi

Ground-breaking immunotherapy research for diseases such as Alzheimer's, Multiple Sclerosis and brain tumors. Every two years the Francqui Foundation awards start-up grants to excellent young researchers under 40. This year the prestigious Collen-Francqui start-up grant goes to VUB professor Kiavash Movahedi, who leads the Kiavash Movahedi lab of the Laboratory for Molecular and Cellular Therapy (LMCT) at the Brussels Health Campus. The Collen-Francqui grant now provides Prof. Movahedi 200. Euro in funding to further develop his promising research. In addition to the financial allowance this three-year mandate also includes a research chair. Prof. Movahedi studies how a class of immune cells called macrophages affect the development and progression of brain disorders.